Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anticholesteremic Agents | 2 | 2007 | 968 | 0.280 |
Why?
|
| Cholesterol, LDL | 2 | 2007 | 2380 | 0.270 |
Why?
|
| Chlamydophila Infections | 1 | 2004 | 23 | 0.230 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2004 | 53 | 0.230 |
Why?
|
| Galactorrhea | 1 | 2002 | 23 | 0.210 |
Why?
|
| Anemia, Refractory, with Excess of Blasts | 1 | 2002 | 17 | 0.210 |
Why?
|
| Cholesterol, HDL | 2 | 2007 | 1812 | 0.200 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2002 | 96 | 0.200 |
Why?
|
| Hyperprolactinemia | 1 | 2002 | 124 | 0.190 |
Why?
|
| Hypercholesterolemia | 2 | 2007 | 1141 | 0.190 |
Why?
|
| Punctures | 1 | 2002 | 366 | 0.190 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2007 | 3245 | 0.190 |
Why?
|
| Nipples | 1 | 2002 | 229 | 0.180 |
Why?
|
| Dideoxynucleosides | 1 | 2001 | 135 | 0.180 |
Why?
|
| Coronary Disease | 2 | 2005 | 5921 | 0.170 |
Why?
|
| Angina Pectoris | 1 | 2002 | 959 | 0.150 |
Why?
|
| Antibodies, Bacterial | 1 | 2004 | 1464 | 0.150 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2001 | 621 | 0.140 |
Why?
|
| Particulate Matter | 3 | 2015 | 2597 | 0.140 |
Why?
|
| Urinary Tract Infections | 1 | 2002 | 801 | 0.130 |
Why?
|
| Thrombophlebitis | 1 | 1995 | 289 | 0.120 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2001 | 1724 | 0.120 |
Why?
|
| Anger | 1 | 1996 | 405 | 0.110 |
Why?
|
| Heart Rate | 2 | 2015 | 4197 | 0.110 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2015 | 577 | 0.100 |
Why?
|
| Violence | 2 | 1996 | 935 | 0.100 |
Why?
|
| Coronary Artery Bypass | 1 | 2001 | 2193 | 0.100 |
Why?
|
| Hyperglycemia | 1 | 2001 | 1375 | 0.100 |
Why?
|
| C-Reactive Protein | 1 | 2004 | 3821 | 0.100 |
Why?
|
| Hyperkalemia | 1 | 1994 | 233 | 0.100 |
Why?
|
| Myocardial Ischemia | 1 | 2001 | 2133 | 0.090 |
Why?
|
| Autonomic Nervous System | 1 | 2015 | 704 | 0.090 |
Why?
|
| Deoxyguanosine | 1 | 2009 | 92 | 0.080 |
Why?
|
| Evidence-Based Medicine | 3 | 2007 | 3691 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 2138 | 0.070 |
Why?
|
| Urban Population | 1 | 2014 | 2036 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 6506 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2002 | 7400 | 0.060 |
Why?
|
| Cardiovascular Diseases | 4 | 2007 | 15521 | 0.060 |
Why?
|
| HIV Infections | 2 | 2002 | 17348 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2015 | 2569 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3114 | 0.050 |
Why?
|
| Stavudine | 1 | 2002 | 85 | 0.050 |
Why?
|
| Heart Diseases | 1 | 2015 | 2795 | 0.050 |
Why?
|
| Mental Health | 1 | 1996 | 3251 | 0.050 |
Why?
|
| Pancytopenia | 1 | 2002 | 102 | 0.050 |
Why?
|
| Alkynes | 1 | 2002 | 320 | 0.050 |
Why?
|
| Lamivudine | 1 | 2002 | 366 | 0.050 |
Why?
|
| Cyclopropanes | 1 | 2002 | 432 | 0.050 |
Why?
|
| Benzoxazines | 1 | 2002 | 316 | 0.040 |
Why?
|
| Cosmetic Techniques | 1 | 2002 | 147 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2015 | 4479 | 0.040 |
Why?
|
| Oxazines | 1 | 2002 | 349 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 1996 | 4413 | 0.040 |
Why?
|
| Primary Health Care | 1 | 1996 | 4679 | 0.040 |
Why?
|
| DNA Damage | 1 | 2009 | 2443 | 0.040 |
Why?
|
| Humans | 18 | 2015 | 761222 | 0.040 |
Why?
|
| Probability | 1 | 2002 | 2478 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2001 | 12159 | 0.030 |
Why?
|
| Mental Disorders | 1 | 1996 | 6823 | 0.030 |
Why?
|
| Physical Examination | 1 | 2002 | 1255 | 0.030 |
Why?
|
| Air Pollutants | 1 | 2009 | 2889 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 10756 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2002 | 1390 | 0.030 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2002 | 1895 | 0.030 |
Why?
|
| Homosexuality, Male | 1 | 2001 | 1336 | 0.030 |
Why?
|
| Cholesterol, Dietary | 1 | 1992 | 224 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2001 | 6304 | 0.020 |
Why?
|
| Pneumonia | 1 | 2002 | 2142 | 0.020 |
Why?
|
| Hypertension | 1 | 2009 | 8536 | 0.020 |
Why?
|
| Adult | 6 | 2015 | 221120 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 12976 | 0.020 |
Why?
|
| Regression Analysis | 1 | 1996 | 6345 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 1996 | 2317 | 0.020 |
Why?
|
| Female | 7 | 2015 | 392552 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 7407 | 0.020 |
Why?
|
| Life Style | 1 | 1996 | 3907 | 0.010 |
Why?
|
| Male | 6 | 2015 | 360703 | 0.010 |
Why?
|
| Middle Aged | 5 | 2015 | 220858 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2009 | 2227 | 0.010 |
Why?
|
| Cholesterol | 1 | 1992 | 2902 | 0.010 |
Why?
|
| Young Adult | 3 | 2015 | 59222 | 0.010 |
Why?
|
| Risk Factors | 2 | 2001 | 74241 | 0.010 |
Why?
|
| Boston | 1 | 2014 | 9327 | 0.010 |
Why?
|
| Aged | 4 | 2015 | 169292 | 0.010 |
Why?
|
| Anticoagulants | 1 | 1995 | 4795 | 0.010 |
Why?
|
| Age Factors | 1 | 1994 | 18384 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2002 | 64681 | 0.010 |
Why?
|
| Inflammation | 1 | 2014 | 10759 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 39127 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2009 | 22174 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2015 | 80675 | 0.000 |
Why?
|
Concepts
(92)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_